Bian Shi-Zhu, Zhang Chen, Rao Rong-Sheng, Ding Xiao-Han, Huang Lan
Department of Cardiology, Xinqiao Hospital, Institute of Cardiovascular Diseases, Army Medical University (Third Military Medical University), Chongqing, China.
Department of Ultrasonography, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Front Cardiovasc Med. 2022 Jun 10;9:866093. doi: 10.3389/fcvm.2022.866093. eCollection 2022.
Elevated pulmonary artery pressure (ePAP) in response to high-altitude hypoxia is a critical physiopathological factor in the hypoxic adaptation that may lead to high-altitude pulmonary edema in the acute phase or high-altitude pulmonary hypertension in the long term. However, the sea-level predictors of risk factors for altitude-induced ePAP have not been examined. Thus, we aimed to identify the baseline systemic blood predictors of ePAP after acute high-altitude exposure.
A total of 154 participants were transported to a high altitude 3,700 m from sea level within 2 h. Echocardiography examinations were performed to assess the mean pulmonary artery pressure (mPAP) and hemodynamics at both altitudes. All the individuals underwent blood tests to determine the concentrations of vascular regulatory factors. Univariate and adjusted logistic regression analyses were performed to identify the independent predictors of ePAP and factors related to ePAP.
The mPAP increased significantly from sea level to high altitude (19.79 ± 6.53-27.16 ± 7.16 mmHg, < 0.05). Increased levels of endothelin (ET-1), Ang (1-7), Ang II, and bradykinin were found after high-altitude exposure, while the levels of nitric oxide (NO), prostaglandin E2 (PEG2), and serotonin decreased sharply (all -values < 0.05). At high altitude, 52.6% of the subjects exhibited ePAP, and the mPAP was closely correlated with the baseline Ang II level ( = 0.170, = 0.036) and follow-up levels of NO ( = -0.209, = 0.009), Ang II ( = 0.246, = 0.002), and Ang (1-7) ( = -0.222, = 0.006) and the left atrial inner diameter (LAD, = 0.270, < 0.001). Both the baseline and follow-up NO and Ang II levels were significantly different between the ePAP and non-ePAP groups. Finally, we identified the baseline Ang II and NO concentrations as two independent predictors of ePAP ( < 0.05). We also found that two vascular regulatory factors with inverse roles, namely, Ang (1-7) and Ang II, at high altitudes were independently associated with ePAP. Additionally, ET-1, NO, PEG2, and LAD were associated with ePAP.
The baseline concentrations of Ang II and NO at sea level are two independent predictors of ePAP after acute high-altitude exposure. Furthermore, Ang (1-7) and Ang II combined with ET-1, NO, PEG2, and LAD at high altitudes may contribute to the development of ePAP.
对高海拔低氧的反应中肺动脉压力升高(ePAP)是低氧适应中的一个关键生理病理因素,在急性期可能导致高海拔肺水肿,长期则可能导致高海拔肺动脉高压。然而,海拔诱导的ePAP危险因素的海平面预测指标尚未得到研究。因此,我们旨在确定急性高海拔暴露后ePAP的基线全身血液预测指标。
总共154名参与者在2小时内从海平面被转运至3700米的高海拔地区。进行超声心动图检查以评估两个海拔高度的平均肺动脉压力(mPAP)和血流动力学。所有个体均接受血液检测以确定血管调节因子的浓度。进行单变量和校正逻辑回归分析以确定ePAP的独立预测指标以及与ePAP相关的因素。
从海平面到高海拔,mPAP显著升高(19.79±6.53 - 27.16±7.16 mmHg,P<0.05)。高海拔暴露后发现内皮素(ET-1)、血管紧张素(1-7)、血管紧张素II和缓激肽水平升高,而一氧化氮(NO)、前列腺素E2(PEG2)和血清素水平急剧下降(所有P值<0.05)。在高海拔地区,52.6%的受试者出现ePAP,mPAP与基线血管紧张素II水平(r = 0.170,P = 0.036)、随访时的NO水平(r = -0.209,P = 0.009)、血管紧张素II水平(r = 0.246,P = 0.002)、血管紧张素(1-7)水平(r = -0.222,P = 0.006)以及左心房内径(LAD,r = 0.270,P<0.001)密切相关。ePAP组和非ePAP组之间的基线和随访时的NO及血管紧张素II水平均有显著差异。最后,我们确定基线血管紧张素II和NO浓度为ePAP的两个独立预测指标(P<0.05)。我们还发现,在高海拔地区起相反作用的两个血管调节因子,即血管紧张素(1-7)和血管紧张素II,与ePAP独立相关。此外,ET-1、NO、PEG2和LAD与ePAP相关。
海平面时血管紧张素II和NO的基线浓度是急性高海拔暴露后ePAP的两个独立预测指标。此外,高海拔时血管紧张素(1-7)和血管紧张素II与ET-1、NO、PEG2和LAD共同作用可能促进ePAP的发展。